Device Trial Radar · NCT06235190
Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential Tremor
Last checked: Nov 19, 2026Latest source record: Jul 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
125
Actual
Start
Feb 27, 2024
Primary completion
Oct 31, 2024
Study completion Nov 6, 2025
Sponsor
- Lead sponsor
- Fasikl Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 31, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical study is to compare Felix NeuroAI Wristband and sham device in patients with essential tremor. The main question it aims to answer is: • Is Felix a safe and efficacious treatment for patients with essential tremor? Participants will be treated with either Felix or Sham for a period of up to 90 days. After that, they will be eligible to participate in a long-term, open-label study and be treated with Felix.
Conditions
- Essential Tremor
Interventions
Felix NeuroAI WristbandDevice
The Felix NeuroAI Wristband (Felix) is a wrist-worn, noninvasive, transcutaneous neurostimulation system. Using a proprietary artificial intelligence (AI) algorithm, stimulation will be automatically adapted to patient's needs with the goal to provide full day relief of upper limb tremor.
Sham DeviceDevice
The sham device has the same exterior appearance and components as the Felix device and is used the same way (without delivering the treatment).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS) Modified Activities of Daily Living (mADL) Score From Baseline Pre-stimulation to Day 90Time frame: 90 days
Locations
12 sites in 2 countries. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona
Parkinson's Research Centers of America - Palo Alto
Palo Alto, California
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.